Log in to save to my catalogue

P63 and P73 Activation in Cancers with p53 Mutation

P63 and P73 Activation in Cancers with p53 Mutation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6fbba4656e7444acaf561a3bb67fda31

P63 and P73 Activation in Cancers with p53 Mutation

About this item

Full title

P63 and P73 Activation in Cancers with p53 Mutation

Publisher

Basel: MDPI AG

Journal title

Biomedicines, 2022-06, Vol.10 (7), p.1490

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

The members of the p53 family comprise p53, p63, and p73, and full-length isoforms of the p53 family have a tumor suppressor function. However, p53, but not p63 or p73, has a high mutation rate in cancers causing it to lose its tumor suppressor function. The top and second-most prevalent p53 mutations are missense and nonsense mutations, respective...

Alternative Titles

Full title

P63 and P73 Activation in Cancers with p53 Mutation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6fbba4656e7444acaf561a3bb67fda31

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6fbba4656e7444acaf561a3bb67fda31

Other Identifiers

ISSN

2227-9059

E-ISSN

2227-9059

DOI

10.3390/biomedicines10071490

How to access this item